| 160 |
decreased |
nitric-oxide synthase activity
(GO:0004517)
|
nitric oxide synthase, brain
(PR:000011326)
|
147: Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307
|
| 159 |
decreased |
Decreased liver function
(HP:0001410)
|
|
164: Induction, Liver “Dysfunctional” Changes by CGA 330050
|
| 158 |
increased |
metabolic process
(GO:0008152)
|
metabolite
(CHEBI:25212)
|
77: Production, Critical Metabolites (CGA 330050 and CGA 265307)
|
| 157 |
increased |
metabolic process
(GO:0008152)
|
thiamethoxam
(CHEBI:39185)
|
77: Production, Critical Metabolites (CGA 330050 and CGA 265307)
|
| 156 |
occurrence |
|
Cyanosis
(MESH:D003490)
|
321: N/A, Cyanosis occurs
|
| 155 |
decreased |
|
hemoglobin
(CHEBI:35143)
|
173: N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number
|
| 154 |
increased |
|
Methemoglobinemia
(MESH:D008708)
|
173: N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number
|
| 153 |
increased |
|
hemosiderosis
(MESH:D006486)
|
161: Increase, Liver and splenic hemosiderosis
|
| 152 |
increased |
liver vascular congestion
(MP:0010019)
|
|
246: Increase, RBC congestion in liver
|
| 151 |
increased |
|
erythrocyte
(CL:0000232)
|
2 Events
|
| 150 |
decreased |
gene expression
(GO:0010467)
|
glucose-6-phosphate 1-dehydrogenase
(PR:000007749)
|
131: Down Regulation, Gulcose-6-phosphate dehydrogenase
|
| 149 |
increased |
hemoglobin binding
(GO:0030492)
|
|
118: Formation, Formation of hemoglobin adducts
|
| 148 |
increased |
hemoglobin biosynthetic process
(GO:0042541)
|
xenobiotic
(CHEBI:35703)
|
118: Formation, Formation of hemoglobin adducts
|
| 147 |
increased |
|
hemolysis
(MESH:D006461)
|
250: Damaging, Red blood cells; hemolysis
|
| 146 |
abnormal |
gene expression
(GO:0010467)
|
hemoglobin subunit alpha (human)
(PR:P69905)
|
21: Altered regulation, Alpha hemoglobin
|
| 145 |
increased |
heme oxidation
(GO:0006788)
|
|
213: N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)
|
| 144 |
decreased |
estrogen receptor activity
(GO:0030284)
|
estrogen receptor
(PR:000007204)
|
2 Events
|
| 143 |
abnormal |
developmental process
(GO:0032502)
|
reproductive organ
(UBERON:0003133)
|
364: Impaired development of, Reproductive organs
|
| 142 |
abnormal |
larval development
(GO:0002164)
|
|
2 Events
|
| 141 |
abnormal |
reproductive behavior
(GO:0019098)
|
|
363: Altered, Reproductive behaviour
|
| 140 |
increased |
Kidney Diseases
(MESH:D007674)
|
|
252: Increase, Renal pathology due to VTG deposition
|
| 139 |
increased |
gene expression
(GO:0010467)
|
vitellogenins
(MESH:D014819)
|
2 Events
|
| 138 |
increased |
|
vitellogenins
(MESH:D014819)
|
2 Events
|
| 137 |
increased |
estrogen receptor activity
(GO:0030284)
|
estrogen receptor
(PR:000007204)
|
3 Events
|
| 136 |
abnormal |
multi-organism reproductive process
(GO:0044703)
|
|
253: N/A, Reproductive failure
|